Yahoo Finance • 7 days ago

This Magnificent Dividend Stock Has Increased Its Payouts by 500% in 10 Years

There are many dividend stocks on equity markets, but not all are attractive to income investors. Those that go beyond paying a quarterly payout but also consistently raise their dividends -- all while having robust businesses that can sup... Full story

Yahoo Finance • 14 days ago

Zoetis' Stock Is About as Cheap as It's Ever Been. 1 Thing to Know Before You Buy.

Shares in animal pharmaceutical company Zoetis(NYSE: ZTS) have been under a cloud since the release of the company's fourth-quarter earnings report in mid-February. The Q4 numbers were fine, but the company's revenue guidance fell short of... Full story

Yahoo Finance • last month

An Intrinsic Calculation For Zoetis Inc. (NYSE:ZTS) Suggests It's 27% Undervalued

Key Insights The projected fair value for Zoetis is US$230 based on 2 Stage Free Cash Flow to Equity Zoetis is estimated to be 27% undervalued based on current share price of US$167 Analyst price target for ZTS is US$203 which is 12% belo... Full story

Yahoo Finance • last month

Is Zoetis Inc. (ZTS) the Best Weight Loss Drug Stock to Buy According to Analysts?

We recently published a list of 10 Best Weight Loss Drug Stocks to Buy According to Analysts. In this article, we are going to take a look at where Zoetis Inc. (NYSE:ZTS) stands against other best weight loss drug stocks to buy according t... Full story

Yahoo Finance • 2 months ago

Earnings To Watch: Zoetis (ZTS) Reports Q4 Results Tomorrow

Earnings To Watch: Zoetis (ZTS) Reports Q4 Results Tomorrow Animal health company Zoetis (NYSE:ZTS) will be reporting results tomorrow before market open. Here’s what to look for. Zoetis beat analysts’ revenue expectations by 4.1% last q... Full story

Yahoo Finance • 6 months ago

Zoetis Inc.'s (NYSE:ZTS) Intrinsic Value Is Potentially 28% Above Its Share Price

Key Insights Zoetis' estimated fair value is US$249 based on 2 Stage Free Cash Flow to Equity Zoetis' US$195 share price signals that it might be 22% undervalued The US$213 analyst price target for ZTS is 15% less than our estimate of fai... Full story

Yahoo Finance • 7 months ago

Zoetis to Host Webcast and Conference Call on Third Quarter 2024 Financial Results

PARSIPPANY, N.J., September 19, 2024--(BUSINESS WIRE)--Zoetis Inc. (NYSE:ZTS) will host a webcast and conference call at 8:30 a.m. (ET) on Monday, November 4, 2024. Chief Executive Officer Kristin Peck and Executive Vice President and Chie... Full story

Yahoo Finance • 7 months ago

Zoetis (NYSE:ZTS) Ticks All The Boxes When It Comes To Earnings Growth

The excitement of investing in a company that can reverse its fortunes is a big draw for some speculators, so even companies that have no revenue, no profit, and a record of falling short, can manage to find investors. Unfortunately, these... Full story

Yahoo Finance • 7 months ago

Zoetis' (NYSE:ZTS) investors will be pleased with their favorable 58% return over the last five years

The main point of investing for the long term is to make money. Furthermore, you'd generally like to see the share price rise faster than the market. Unfortunately for shareholders, while the Zoetis Inc. (NYSE:ZTS) share price is up 52% in... Full story

Yahoo Finance • 8 months ago

Zoetis to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference

PARSIPPANY, N.J., August 20, 2024--(BUSINESS WIRE)--Zoetis Inc. (NYSE:ZTS) will participate in the Morgan Stanley 22nd Annual Global Healthcare Conference on Wednesday, September 4, 2024. Kristin Peck, Chief Executive Officer, and Wetteny... Full story

Yahoo Finance • 8 months ago

Q2 2024 Zoetis Inc Earnings Call

Participants Steve Frank; Vice President, Investor Relations; Zoetis Inc Kristin Peck; Chief Executive Officer, Director; Zoetis Inc Wetteny Joseph; Chief Financial Officer, Executive Vice President; Zoetis Inc John Block; Analyst; Sti... Full story

Yahoo Finance • 8 months ago

Zoetis Announces Second Quarter 2024 Results

Reports Revenue of $2.4 Billion, Growing 8%, and Net Income of $624 Million, or $1.37 per Diluted Share, Decreasing 7% and 6%, Respectively, on a Reported Basis for Second Quarter 2024 Delivers 11% Operational Growth in Revenue and 18% Op... Full story

Yahoo Finance • 10 months ago

Zoetis Inc. (ZTS): Did this Feminist Stock Soar High in Q1?

We recently compiled a list of the 11 Best Feminist Stocks To Invest In. In this article, we are going to take a look at where Zoetis Inc. (NYSE:ZTS) stands against the other feminist stocks. With the passage of time, the role of women in... Full story

Yahoo Finance • 11 months ago

Calculating The Intrinsic Value Of Zoetis Inc. (NYSE:ZTS)

Key Insights The projected fair value for Zoetis is US$189 based on 2 Stage Free Cash Flow to Equity Current share price of US$171 suggests Zoetis is potentially trading close to its fair value Our fair value estimate is 11% lower than Zo... Full story

Yahoo Finance • 11 months ago

Elanco Animal Health Stock (NYSE:ELAN): Hurdles Remain Despite Hitting 52-Week High

Elanco Animal Health (NYSE:ELAN) is at a 52-week high after the company’s first-quarter earnings release. Not only did the animal health company beat consensus expectations, but it also provided encouraging updates regarding its product pi... Full story

Yahoo Finance • 11 months ago

10 Most Promising Stocks to Buy Before They Take Off

In this article, we discuss the 10 most promising stocks to buy before they take off. To skip the detailed analysis of the current earnings week, go directly to the 5 Most Promising Stocks to Buy Before They Take Off. Meta Grows Revenue b... Full story

Yahoo Finance • 12 months ago

14 Dividend Growth Stocks with Highest Growth Rates

In this article, we discuss 14 dividend growth stocks with highest growth rates. You can skip our detailed analysis of dividend growth stocks and their overall performance, and go directly to read 5 Dividend Growth Stocks with Highest Grow... Full story

Yahoo Finance • 12 months ago

Zoetis (ZTS) Fell After Reporting Mixed Fourth Quarter Results

Baron Funds, an investment management company, released its “Baron Health Care Fund” first quarter 2024 investor letter. A copy of the same can be downloaded here. The fund advanced 8.92% (Institutional Shares) in the quarter compared to a... Full story

Yahoo Finance • last year

Wall Street Analysts Just Trimmed Price Targets for These 10 Stocks

In this article, we will discuss the 10 stocks whose price targets were recently trimmed by analysts. If you want to see more such stocks on the list, go directly to Wall Street Analysts Just Trimmed Price Targets for These 5 Stocks. Amid... Full story

Yahoo Finance • last year

Zoetis Inc. (NYSE:ZTS) Q4 2023 Earnings Call Transcript

Zoetis Inc. (NYSE:ZTS) Q4 2023 Earnings Call Transcript February 14, 2024 Zoetis Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Welcome to the Fourth Quart... Full story